These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 37369741)
1. Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in TP53, KMT genes and PDGFB fusions. Das S; Idate R; Lana SE; Regan DP; Duval DL Sci Rep; 2023 Jun; 13(1):10422. PubMed ID: 37369741 [TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in Das S; Idate R; Lana SE; Regan DP; Duval DL bioRxiv; 2023 Jan; ():. PubMed ID: 36711648 [TBL] [Abstract][Full Text] [Related]
3. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing. Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853 [TBL] [Abstract][Full Text] [Related]
4. Primary cardiac undifferentiated pleomorphic sarcoma is associated with TP53 mutation during lack of MDM2 amplification, and targeted sequencing analysis reveals potentially actionable targets. Cui Y; Han L; Shang J; Fang W; Zhao M; Chen D; Liu H Hum Pathol; 2022 May; 123():113-122. PubMed ID: 35181378 [TBL] [Abstract][Full Text] [Related]
5. Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma. Suehara Y; Kohsaka S; Hayashi T; Akaike K; Kurisaki-Arakawa A; Sato S; Kobayashi E; Mizuno S; Ueno T; Morii T; Okuma T; Kurihara T; Hasegawa N; Sano K; Sasa K; Okubo T; Kim Y; Mano H; Saito T Clin Orthop Relat Res; 2021 Apr; 479(4):838-852. PubMed ID: 33196586 [TBL] [Abstract][Full Text] [Related]
6. Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone. Ali NM; Niada S; Brini AT; Morris MR; Kurusamy S; Alholle A; Huen D; Antonescu CR; Tirode F; Sumathi V; Latif F J Pathol; 2019 Feb; 247(2):166-176. PubMed ID: 30281149 [TBL] [Abstract][Full Text] [Related]
7. Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma. Nakayama R; Nemoto T; Takahashi H; Ohta T; Kawai A; Seki K; Yoshida T; Toyama Y; Ichikawa H; Hasegawa T Mod Pathol; 2007 Jul; 20(7):749-59. PubMed ID: 17464315 [TBL] [Abstract][Full Text] [Related]
8. p53 immunohistochemical analysis of fusion-positive uterine sarcomas. Mohammad N; Stewart CJR; Chiang S; Turashvili G; Dickson BC; Ng TL; Köbel M; McCluggage WG; Croce S; Lee CH Histopathology; 2021 May; 78(6):805-813. PubMed ID: 33118176 [TBL] [Abstract][Full Text] [Related]
9. Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets. Kim J; Kim JH; Kang HG; Park SY; Yu JY; Lee EY; Oh SE; Kim YH; Yun T; Park C; Cho SY; You HJ BMC Med Genet; 2018 Dec; 19(Suppl 1):216. PubMed ID: 30598078 [TBL] [Abstract][Full Text] [Related]